Pre-Market: QLGN Soars Over 330%, Previously Received $41 Million Investment from Faraday Future and Transformed into a Crypto Company

BlockBeats News, September 22nd, according to market data, Qualigen Therapeutics (QLGN) surged 333.8% in pre-market trading to $12.32.

Earlier reports indicated that on September 20th, Faraday Future (NASDAQ: FFAI) announced a $41 million PIPE transaction to strategically invest in Qualigen Therapeutics (NASDAQ: QLGN), which will be renamed CXC10 and transformed into a crypto and Web3 business platform.